University of Cincinnati researchers are presenting abstracts at the European Stroke Organization Conference (ESOC) 2023, May 24-26 in Munich, Germany, including the results of the first large-scale assessment of radiological ...
May 26, 2023
0
40
Many parts of rural America with less access to health care also have limited broadband internet that could help them take advantage of increasingly popular online health services.
Mar 24, 2023
0
16
Newly published research from the University of Cincinnati finds that people with latent tuberculosis infection (LTBI) have more inflammation and could be at a higher risk for cardiovascular disease.
Jan 6, 2023
0
40
Everyone has times where their mind won't stay on task. For example, you might be listening to someone talk in a meeting or class and your mind wanders to your dinner plans. Notably, research suggests that 30% to 50% of our ...
Dec 15, 2021
0
27
An experimental vaccine study currently under way at the UC Cancer Institute aims to prevent ovarian cancer recurrence by triggering the body’s natural defense system.
Mar 2, 2012
0
0
Engineers at the University of Cincinnati have developed a new device that can warn consumers about early risks of tooth decay from diseases such as gingivitis and periodontitis.
Sep 7, 2023
0
8
Among women who are kidney transplant recipients, Hispanic women have a higher likelihood of pregnancy than white women, according to new research from the University of Cincinnati (UC). The study, published in the PLOS ONE ...
Aug 12, 2019
0
9
Hepatitis C is a very sneaky creature that coats itself in an envelope which changes every time the body tries to mount an immune response, says Kenneth Sherman, MD, PhD, a UC Health physician and professor in University ...
May 29, 2014
0
0
A University of Cincinnati immunologist is recommending that individuals with contact dermatitis choose facial masks made without elastic or rubber that allow them to stay safe in the midst of COVID-19 while avoiding possible ...
Nov 13, 2020
0
18
Researchers have found that using a combination of sofosbuvir and a new drug agent known as daclastasvir is highly successful in treating co-infected hepatitis C (HCV) and HIV patients.
Jul 22, 2015
0
36
